These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Predictive Performance of Prospectively Applied ISUP and Fuhrman Grade in Nonmetastatic Renal Cell Carcinoma. Galtung KF; Lauritzen PM; Baco E; Berg RE; Naas AM; Rud E Anticancer Res; 2022 Jun; 42(6):2967-2975. PubMed ID: 35641263 [TBL] [Abstract][Full Text] [Related]
25. High WHO/ISUP Grade and Unfavorable Architecture, Rather Than Typing of Papillary Renal Cell Carcinoma, May Be Associated With Worse Prognosis. Yang C; Shuch B; Kluger H; Humphrey PA; Adeniran AJ Am J Surg Pathol; 2020 May; 44(5):582-593. PubMed ID: 32101890 [TBL] [Abstract][Full Text] [Related]
26. Critical analysis of a simplified Fuhrman grading scheme for prediction of cancer specific mortality in patients with clear cell renal cell carcinoma--Impact on prognosis. Becker A; Hickmann D; Hansen J; Meyer C; Rink M; Schmid M; Eichelberg C; Strini K; Chromecki T; Jesche J; Regier M; Randazzo M; Tilki D; Ahyai S; Dahlem R; Fisch M; Zigeuner R; Chun FK Eur J Surg Oncol; 2016 Mar; 42(3):419-25. PubMed ID: 26520403 [TBL] [Abstract][Full Text] [Related]
27. Rhabdoid differentiation is associated with aggressive behavior in renal cell carcinoma: a clinicopathologic analysis of 76 cases with clinical follow-up. Przybycin CG; McKenney JK; Reynolds JP; Campbell S; Zhou M; Karafa MT; Magi-Galluzzi C Am J Surg Pathol; 2014 Sep; 38(9):1260-5. PubMed ID: 25127094 [TBL] [Abstract][Full Text] [Related]
28. Survival pattern of metastatic renal cell carcinoma patients according to WHO/ISUP grade: a long-term multi-institutional study. Choi J; Bang S; Suh J; Choi CI; Song W; Yuk HD; Lee CH; Kang M; Choo SH; Kim JK; Lee HH; Jo JK; Hwang EC; Jeong CW; Ko YH; Park JY; Song C; Seo SI; Chung J; Kwak C; Hong SH Sci Rep; 2024 Feb; 14(1):4740. PubMed ID: 38413653 [TBL] [Abstract][Full Text] [Related]
29. Prediction of World Health Organization /International Society of Urological Pathology (WHO/ISUP) Pathological Grading of Clear Cell Renal Cell Carcinoma by Dual-Layer Spectral CT. Zhang X; Zhang G; Xu L; Bai X; Zhang J; Chen L; Lu X; Yu S; Jin Z; Sun H Acad Radiol; 2023 Oct; 30(10):2321-2328. PubMed ID: 36543688 [TBL] [Abstract][Full Text] [Related]
30. Advances in renal neoplasia: recommendations from the 2012 International Society of Urological Pathology Consensus Conference. Delahunt B; Srigley JR; Montironi R; Egevad L Urology; 2014 May; 83(5):969-74. PubMed ID: 24661331 [TBL] [Abstract][Full Text] [Related]
31. Grading of clear cell renal cell carcinoma should be based on nucleolar prominence. Delahunt B; Sika-Paotonu D; Bethwaite PB; William Jordan T; Magi-Galluzzi C; Zhou M; Samaratunga H; Srigley JR Am J Surg Pathol; 2011 Aug; 35(8):1134-9. PubMed ID: 21716085 [TBL] [Abstract][Full Text] [Related]
33. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma. Ficarra V; Martignoni G; Maffei N; Brunelli M; Novara G; Zanolla L; Pea M; Artibani W Cancer; 2005 Jan; 103(1):68-75. PubMed ID: 15573369 [TBL] [Abstract][Full Text] [Related]
34. The prognostic significance of the 2014 International Society of Urological Pathology (ISUP) grading system for prostate cancer. Samaratunga H; Delahunt B; Gianduzzo T; Coughlin G; Duffy D; LeFevre I; Johannsen S; Egevad L; Yaxley J Pathology; 2015 Oct; 47(6):515-9. PubMed ID: 26325670 [TBL] [Abstract][Full Text] [Related]
35. The chromophobe tumor grading system is the preferred grading scheme for chromophobe renal cell carcinoma. Finley DS; Shuch B; Said JW; Galliano G; Jeffries RA; Afifi AA; Castor B; Magyar C; Sadaat A; Kabbinavar FF; Belldegrun AS; Pantuck AJ J Urol; 2011 Dec; 186(6):2168-74. PubMed ID: 22014797 [TBL] [Abstract][Full Text] [Related]
36. 2-[ Zhao Y; Wu C; Li W; Chen X; Li Z; Liao X; Cui Y; Zhao G; Liu M; Fu Z Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):570-579. PubMed ID: 32814979 [TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical Panel for Differentiating Renal Cell Carcinoma with Clear and Papillary Features. Alshenawy HA Pathol Oncol Res; 2015 Sep; 21(4):893-9. PubMed ID: 25712789 [TBL] [Abstract][Full Text] [Related]
38. [International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia 2012]. Hes O Cesk Patol; 2014; 50(4):137-41. PubMed ID: 25418900 [TBL] [Abstract][Full Text] [Related]
39. CT-based radiomics model using stability selection for predicting the World Health Organization/International Society of Urological Pathology grade of clear cell renal cell carcinoma. Zhang H; Yin F; Chen M; Qi A; Yang L; Wen G Br J Radiol; 2024 May; 97(1158):1169-1179. PubMed ID: 38688660 [TBL] [Abstract][Full Text] [Related]
40. Predictive value of the 2014 International Society of Urological Pathology grading system for prostate cancer in patients undergoing radical prostatectomy with long-term follow-up. Grogan J; Gupta R; Mahon KL; Stricker PD; Haynes AM; Delprado W; Turner J; Horvath LG; Kench JG BJU Int; 2017 Nov; 120(5):651-658. PubMed ID: 28371244 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]